1993
DOI: 10.1021/jm00061a022
|View full text |Cite
|
Sign up to set email alerts
|

5-Chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase

Abstract: A series of highly potent, structurally novel, non-nucleoside RT inhibitors has been described. Low nanomolar concentrations of 5-chloro-3-(phenylsulfonyl)-indole-2-carboxamide (1) inhibit the HIV-1 RT enzyme in vitro and HTLVIIIb viral spread in MT-4 human T-lymphoid cells. Good oral bioavailability was observed in rhesus monkeys upon oral dosing of 1 as a suspension in methocel. When compared to other non-nucleoside inhibitors (e.g. 15-18), 1 possesses improved inhibitory potency with respect to the wild-typ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
83
0

Year Published

1996
1996
2017
2017

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 258 publications
(85 citation statements)
references
References 5 publications
2
83
0
Order By: Relevance
“…5 Among them, L-737,126 (4), a benzenesulfonylindolcarboxamide endowed with potent antiviral activity and high selectivity, has been developed by Merck A. G. Despite its highest activity, L-737,126 was not suitable for clinical trials, because of its low bioavailability rising from its scarce solubility in water. 13 Merck Research Laboratories attempted to overcome this problem by replacing the 2-carboxamide function with some heterocycles (for example compounds 5a-5c), but the new compounds increased only marginally the water solubility of 4. 14 Nevertheless, some of them were found to be active against resistant mutants, with compound 5a being 11 times more active than 4 against the K103N mutant (Chart 2).…”
Section: Introductionmentioning
confidence: 99%
“…5 Among them, L-737,126 (4), a benzenesulfonylindolcarboxamide endowed with potent antiviral activity and high selectivity, has been developed by Merck A. G. Despite its highest activity, L-737,126 was not suitable for clinical trials, because of its low bioavailability rising from its scarce solubility in water. 13 Merck Research Laboratories attempted to overcome this problem by replacing the 2-carboxamide function with some heterocycles (for example compounds 5a-5c), but the new compounds increased only marginally the water solubility of 4. 14 Nevertheless, some of them were found to be active against resistant mutants, with compound 5a being 11 times more active than 4 against the K103N mutant (Chart 2).…”
Section: Introductionmentioning
confidence: 99%
“…Some of the indole alkaloids extracted from plants possess interesting cytotoxic, antitumour or antiparasitic properties [1,2]. Pyrido [1,2-a] indole derivatives have been identified as potent inhibitors of human immunodeficiency virus type-1 [3], and 5-chloro-3-(phenylsulfonyl) indole-2-carboxamide is reported to be a highly potent non-nucleoside inhibitor of HIV-1 reverse transcriptase [4]. The interaction of phenylsulfonylindole with calf thymus DNA has also been studied by spectroscopic methods [5].…”
Section: Introductionmentioning
confidence: 99%
“…Among them, 5-chloro-3-(phenylsulfonyl)indole-2-carboxamide derivatives were found to be HIV-1 reverse transcriptase inhibitors with IC 50 values in the nM range (Williams et al, 1993). An indole-containing compound, delavirdine ( Fig.…”
Section: Introductionmentioning
confidence: 99%